Articles related to Pharmacy (Community)

The FDA notice added that a letter was sent out about the recall. However, it did not include a press release or other specific details.

“This device will become many patients’ primary epinephrine device because it removes the hurdle to administering epinephrine earlier in the anaphylactic process.” — Haley Overstreet, MD, Aspire Allergy & Sinus

“Today’s approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment.” – Iilun Murphy, MD, Director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research

64% of those who self-administered Cardamyst converted to sinus rhythm within 30 minutes compared with 31% who received placebo.

“The key word is association. This study does not establish causality. For absolute, catastrophic harm to an appropriately selected, monitored pain patient, the risk is small.” – Sean Mackey, MD, PhD, Chief of the Division of Stanford Pain Medicine

Clinicians often are unaware that gabapentinoids can cause peripheral edema or even respiratory depression.